Member Info for TrickyEFC

Shares in Issue 376.72m

Market Capitalisation £84.76k

Cheap as chips.............

£800,000 (approximately US$1.06 million), before expenses, through the issue of 3,636,363,633 they have issued 10 times that in last fundraise

Any chance of a Friday afternoon rally

Looks like they are daffy

If those two large trades where a roll over then buy v sells today is level

I was guilty last time but can we make a deal no body respond to one day wonders. That would be cool 😜

Buyers back

News on svns 14 next month.

As for the other products could be anytime

SVN 14

1. In-vitro screening for SERT, DAT and NET re-absorption inhibition

2. In-vitro screening for SERT, DAT and NET release - expected to complete by the end of July 2025

3. Pre-clinical animal testing

4. Lead candidate selection - expected by the end of Q3 2025

And normal for cu nts like that nob and his mates on Monday to act like gob shores 😜

And sod this am straight back off into the sunshine

Due to the lse share count knock £1.9 million of displayed market cap.

Soo cheap

21 January 2025

Solvonis Therapeutics plc

("Solvonis" or the "Company")

Update on FDA Pre-IND Meeting for Awakn Life Sciences' Drug Candidate AWKN-002

· FDA supports AWKN-002's progression to Phase 2b clinical trial without requirement for additional clinical data

· FDA endorses use of 505(b)(2) NDA pathway, enabling a streamlined regulatory process and potential for faster market access

· AWKN-002 is being developed for the treatment of alcohol use disorder in the U.S.

*providing

I wonder if Solvonis have or will be provided the lions share of the drug application before the trial is complete.

😜💪

Could get crazy here

Wonder if we get a interviewregarding these developments from one of the team.

Llama thank you for posting that it is kind and massive and very relevant to Solvonis.

How about this bit.

Brilliant

“Using a common-sense approach, the national priority review program will allow companies to submit the lion’s share of the drug application before a clinical trial is complete so that we can reduce inefficiencies

Llama talk about timing that doc was published on June 17, 2025.

So the potential could be released in as little as 1/2 months

He likes innovation

As FDA Commissioner, Dr. Makary has stated his commitment to ensuring the FDA upholds a "gold standard of trusted science, transparency, and common sense". He also emphasized the importance of innovation and public safety in his remarks to FDA staff.

After hour buy 16:50:50 0.195 5,000,000 Buy* 9,750

It nearly got us back to the 2s